Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Jefferies Financial
JEF
5
Amazon
AMZN
CA Stock MarketDetailed Quotes
NGMD NuGen Medical Devices Inc
- 0.070
- 0.0000.00%
15min DelayTrading May 14 16:00 ET
15.24MMarket Cap-3.50P/E (TTM)
0.000High0.000Low0Volume0.000Open0.070Pre Close0.00Turnover0.15552wk High0.00%Turnover Ratio217.73MShares0.04052wk Low-0.02EPS TTM14.89MFloat Cap0.530Historical HighLossP/E (Static)212.76MShs Float0.035Historical Low-0.02EPS LYR0.00%Amplitude--Dividend TTM-2.69P/B1Lot Size--Div YieldTTM
NuGen Medical Devices Inc Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 29.79%-4.71M | -123.87%-2.79M | 1.79%-893.56K | 91.45%-214.56K | 60.28%-813.44K | -215.07%-6.71M | -704.17%-1.25M | -237.60%-909.88K | -299.85%-2.51M | -89.82%-2.05M |
| Net income from continuing operations | 44.18%-5.23M | 119.82%510.23K | -29.62%-2.96M | 60.29%-950.87K | 13.48%-1.83M | -67.84%-9.36M | -47.43%-2.57M | -147.02%-2.28M | -69.25%-2.39M | -41.38%-2.11M |
| Operating gains losses | -3,273.49%-2.05M | ---2.05M | --451.72K | -2,764.96%-487.24K | -65.64%35.83K | --64.53K | ---- | ---- | 89.73%-17.01K | 501.22%104.28K |
| Depreciation and amortization | -6.53%645.73K | 3.57%158.14K | -12.93%155.42K | -10.52%159.89K | -4.80%172.28K | 5.89%690.84K | -19.25%152.69K | 2.94%178.5K | 28.92%178.69K | 19.61%180.96K |
| Remuneration paid in stock | -93.06%94.69K | --0 | -6.43%44.18K | --0 | -91.12%50.51K | 215.92%1.36M | 128.39%443.5K | 21,961.21%47.21K | 267.36%304.14K | 268.22%569.12K |
| Deferred tax | -80.06%6.74K | -115.60%-3.97K | 1,147.03%10.71K | ---- | ---- | 963.10%33.8K | 1,904.09%25.47K | 2,554.29%859 | ---- | ---- |
| Other non cashItems | 75.13%2.15M | 233.68%715.73K | 1.40%364.24K | 136.20%765.56K | -7.36%306.87K | -30.13%1.23M | -20.15%214.49K | -53.63%359.19K | 0.49%324.12K | -15.76%331.26K |
| Change In working capital | 53.19%-339.78K | -600.86%-2.13M | 18.95%1.05M | 132.70%298.1K | 139.85%447.42K | -220.20%-725.79K | -54.61%426.26K | 282.62%882.49K | -322.80%-911.65K | -329.95%-1.12M |
| -Change in receivables | 208.35%104.92K | -232.15%-36.28K | -11.37%-157.48K | -47.54%52.1K | 400.01%246.58K | -255.14%-96.83K | 173.79%27.46K | -161.65%-141.41K | 355.94%99.31K | 9.63%-82.19K |
| -Change in inventory | 15.90%-111.44K | 113.04%16.39K | 4,040.67%196.6K | -4,300.24%-345.9K | 260.12%21.47K | -107.46%-132.51K | -104.61%-125.63K | 13.26%-4.99K | -752.60%-7.86K | 42.11%5.96K |
| -Change in prepaid assets | 170.83%95.79K | -107.60%-32.69K | -102.02%-15.38K | 104.21%23.51K | 115.64%120.35K | -212.60%-135.23K | 74.69%430.41K | 314.35%762.73K | -548.47%-558.67K | -1,218.45%-769.7K |
| -Change in payables and accrued expense | -21.89%-459.19K | -997.21%-1.78M | 361.61%1.1M | 127.23%146.13K | 126.73%74.19K | -161.58%-376.73K | -73.67%198.64K | 156.07%238.87K | -234.39%-536.64K | -139.23%-277.6K |
| -Change in other working capital | 94.28%30.15K | -186.99%-300.22K | -381.19%-76.71K | 357.91%422.26K | -2,486.79%-15.18K | -57.81%15.52K | ---104.61K | --27.28K | --92.22K | --636 |
| Tax refund paid | --0 | 1,071,100.00%10.71K | ---- | ---- | ---- | -161.81%-8.32K | 100.08%1 | ---- | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 29.79%-4.71M | -123.87%-2.79M | 1.81%-893.56K | 91.45%-214.56K | 60.28%-813.44K | -215.07%-6.71M | -704.17%-1.25M | -237.67%-910.06K | -299.82%-2.51M | -89.82%-2.05M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 77.63%-11.94K | -218.49%-10.82K | 99.25%-375 | -375 | -375 | -5,202.58%-53.4K | -3.4K | -50K | 0 | 0 |
| Net PPE purchase and sale | -243.32%-10.38K | ---- | ---- | ---- | ---- | -200.10%-3.02K | ---- | ---- | ---- | ---- |
| Net other investing changes | 96.89%-1.57K | -18.40%-444 | ---375 | ---375 | ---375 | ---50.38K | ---375 | ---- | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 77.63%-11.94K | -218.49%-10.82K | 99.25%-375 | ---375 | ---375 | -5,202.58%-53.4K | ---3.4K | ---50K | --0 | --0 |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 57.84%11.21M | 710.52%405K | 662.80%10.07M | -100.21%-7.03K | -68.53%744.23K | 1,282.02%7.1M | -46.58%49.97K | 213.98%1.32M | 4,388.53%3.37M | 3,252.93%2.36M |
| Net issuance payments of debt | 74.69%9.97M | --0 | 32,866.47%10M | 99.14%-7.03K | 34.90%-20.77K | 6,905.04%5.71M | 21,048.57%6.59M | ---30.52K | ---818.83K | ---31.9K |
| Net common stock issuance | ---- | ---- | --0 | --0 | --0 | 878.17%6.58M | --0 | --0 | --4.18M | --2.4M |
| Proceeds from stock option exercised by employees | -11.28%1.24M | 912.50%405K | -95.19%65K | --0 | --765K | --1.39M | --40K | --1.35M | --2K | --0 |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 57.84%11.21M | 710.52%405K | 662.80%10.07M | -100.21%-7.03K | -68.53%744.23K | 1,282.02%7.1M | -46.58%49.97K | 213.98%1.32M | 4,388.53%3.37M | 3,252.93%2.36M |
| Net cash flow | ||||||||||
| Beginning cash position | 253.33%464.46K | 461.15%9.34M | -86.31%172.92K | -12.85%394.88K | 253.33%464.46K | -92.49%131.45K | 762.74%1.67M | 1,343.58%1.26M | -25.14%453.09K | -92.49%131.45K |
| Current changes in cash | 1,846.37%6.48M | -99.72%-2.4M | 2,451.60%9.17M | -125.88%-221.96K | -121.98%-69.58K | 120.58%333.01K | -1,850.59%-1.2M | 140.07%359.42K | 255.24%857.67K | 127.44%316.6K |
| Effect of exchange rate changes | --0 | --0 | --0 | --0 | --0 | --0 | --0 | 196.97%42.86K | -238.11%-47.89K | -47.06%5.04K |
| End cash Position | 1,395.51%6.95M | 1,395.51%6.95M | 461.15%9.34M | -86.31%172.92K | -12.85%394.88K | 253.33%464.46K | 253.33%464.46K | 762.74%1.67M | 1,343.58%1.26M | -25.14%453.09K |
| Free cash from | 29.67%-4.72M | -124.16%-2.8M | 1.81%-893.56K | 91.45%-214.56K | 60.28%-813.44K | -215.06%-6.72M | -706.12%-1.25M | -236.41%-910.06K | -299.82%-2.51M | -89.82%-2.05M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Market Insights
Warren Buffett Portfolio Warren Buffett Portfolio
Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry. Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry.
Unlock Now
Discussing
Berkshire 2025 highlights: Stepping aside as CEO, trade and market volatility
$Berkshire Hathaway-A (BRK.A.US)$ held its highly anticipated annual shareholders meeting Saturday. Here are some key takeaways from the eve
Buffettttttt
May 3 21:00
Berkshire's 2025 Annual Shareholders Meeting